Orbimed Advisors LLC Olema Pharmaceuticals, Inc. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.75 - $30.71 $7.07 Million - $24.8 Million	-807,792 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$21.15 - $36.14 $3.21 Million - $5.48 Million	151,666 Added 23.12%	807,792 $22.6 Million
Q1 2021 May 17, 2021	BUY	$27.81 - $53.64 $142,776 - $275,387	5,134 Added 0.79%	656,126 $21.8 Million
Q4 2020 Feb 16, 2021	BUY	$37.09 - $54.5 $24.1 Million - $35.5 Million	650,992 New	650,992 $31.3 Million

136

58.7M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $234M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.